Exercise rehabilitation for genetic cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at whether a supervised exercise and rehabilitation program can help people who have a genetic heart condition called arrhythmogenic cardiomyopathy. The program is designed to be safe for people with a higher genetic risk and aims to improve overall heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with arrhythmogenic cardiomyopathy by a specialist using current guidelines.
- A heart test (like an echocardiogram or cardiac MRI) must show that the heart's pumping chambers are affected.
- You must have a confirmed genetic change in one of these genes: LMNA, DSP, FLNC, TMEM43, PLN, or DES.
- Your heart condition must be stable: no hospital stays, serious rhythm problems, or defibrillator shocks in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
This study looks at how exercise affects heart rhythm in people with ARVC, a genetic heart condition. Participation involves supervised exercise sessions and heart monitoring to better understand safe activity levels.
This study looks at people with a genetic heart muscle condition called cardiomyopathy, which can cause irregular heartbeats. By studying your condition, doctors hope to better understand how it develops, how to predict its course, and how to improve diagnosis and treatment.
This study looks at whether a personalized exercise program can improve heart health markers and gene activity in people with coronary artery disease. If you join, you'll take part in a supervised rehabilitation program to see if it helps your heart recovery.
This study tests whether a 12-week supervised exercise program is safe and helpful for people with cardiac amyloidosis and heart failure. It aims to see if regular exercise can improve how you feel and function.
This trial tests whether a personalized exercise program can safely improve fitness and daily activity for people with hypertrophic cardiomyopathy (a heart muscle condition). You would work with experts to build a routine that fits your needs and current health.
Hear when a new Arrhythmogenic Cardiomyopathy (AC, ARVD/C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.